Evidence map›Paper›PMID 41612591›Full record

ArticleAddiction (Abingdon, England)2026

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi-modal neuroimaging.

Yi-Hsuan Liu, Chia-Chun Hung, Marc N Potenza, Kun-Hsien Chou, Pei-Lin Lee, Chu-Chung Huang, Chiang-Shan R Li, Tony Szu-Hsien Lee, Ching-Po Lin

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi-Hsuan LiuInstitute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0001-5976-3035
Chia-Chun HungCenter for Addiction Prevention and Policy Research, National Taiwan Normal University, Taipei, Taiwan.ORCID 0000-0003-1118-8187
Marc N PotenzaDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.ORCID 0000-0002-6323-1354
Kun-Hsien ChouInstitute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pei-Lin LeeCenter for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0002-3041-8710
Chu-Chung HuangSchool of Psychology and Cognitive Science, East China Normal University, Shanghai, China.ORCID 0000-0002-9096-9610
Chiang-Shan R LiDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.ORCID 0000-0002-9393-1212
Tony Szu-Hsien LeeCenter for Addiction Prevention and Policy Research, National Taiwan Normal University, Taipei, Taiwan.ORCID 0000-0003-2574-3372
Ching-Po LinInstitute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0001-6848-8776

Funding

Brain Research Center, National Yang Ming Chiao Tung UniversityCenter for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung UniversityMinistry of Education (MOE)National Science and Technology Council, Taiwan 105-2410-H-003-013National Science and Technology Council, Taiwan 106-2410-H-003-028National Science and Technology Council, Taiwan 107-2410-H-003-038-Y2National Science and Technology Council, Taiwan 109-2410-H-003-017-SS3National Science and Technology Council, Taiwan 109-2917-I-010-002National Science and Technology Council, Taiwan 112-2314-B-A49-056National Science and Technology Council, Taiwan 112-2321-B-A49-008National Science and Technology Council, Taiwan 112-2410-H-003-081-SS2National Science and Technology Council, Taiwan 113-2314-B-A49-070National Science and Technology Council, Taiwan 113-2321-B-A49-015National Science and Technology Council, Taiwan 114-2221-E-A49-104-MY3National Science and Technology Council, Taiwan 114-2314-B-A49-041-MY3National Science and Technology Council, Taiwan 114-2321-B-A49-015National Science and Technology Council, Taiwan 114-2926-I-A49A-501-GTri-Service General Hospital: Advanced National Defense Technology & Research Program
6 · The paper itself

Abstract

BACKGROUND AND

aimsRecreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working-memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear. In Taiwan, ketamine is predominantly consumed by smoking ketamine mixed with tobacco, producing smoking-related behavioral profiles like non-ketamine tobacco use participants (TUs). We therefore examined individuals with urine-confirmed ketamine as the only detected substance who reported predominantly smoking-administered recreational use (KUs) and used TUs as controls. This study aimed to: (1) characterize ketamine-use patterns and psychiatric symptoms; (2) compare working-memory and affective-behavioral measures between KUs and TUs; (3) quantify group differences in hippocampal subregion volumes; and (4) assess group differences in functional connectivity (FC) of identified subregions and relationships with neurotransmitter receptor distributions.

designCross-sectional case-control study with cognitive testing and neuroimaging.

settingCommunity-based recruitment in Taiwan.

participants58 KUs (44 males; mean age = 21.00 ± 4.57) and 73 TUs (52 males; mean age = 24.34 ± 5.86). MEASUREMENTS: Ketamine-use patterns (Addiction Severity Index), psychiatric symptoms [Symptom Checklist-90-Revised (SCL-90-R)], working-memory (N-back), affective-behavioral measures [Barratt Impulsiveness Scale (BIS-11), Buss and Perry Aggression Questionnaire (BPAQ), Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ)], hippocampal subfield volumes (FreeSurfer) and functional connectivity (FC) of identified subregions (seed-based analysis). Spatial correspondence with N-methyl-D-aspartate (NMDA) receptor density was evaluated using JuSpace.

findingsHeavier ketamine use was associated with greater psychological distress [Global Severity Index (GSI) r = 0.343, P = 0.011], particularly anxiety (r = 0.457, P < 0.001) and hostility (r = 0.442, P < 0.001). Although self-reported impulsivity, aggression and reward/punishment sensitivity did not differ between groups, KUs showed reduced accuracy under higher working-memory load [2-back: F(1, 124) = 4.16, P = 0.04, partial η

conclusionsRecreational smoking-administered ketamine use appears to be associated with dose-dependent psychiatric symptoms, load-dependent working memory impairment, selective hippocampal subregion volumetric differences and altered network connectivity aligned with N-methyl-D-aspartate- (NMDA) receptor distribution.

Indexed as

Anesthetics, DissociativeHippocampusKetamineNeuroimagingSubstance-Related DisordersAdultCase-Control StudiesCross-Sectional StudiesDose-Response Relationship, DrugFemaleHumansMagnetic Resonance ImagingMaleMemory, Short-TermMultimodal ImagingNeuropsychological TestsAnesthetics, DissociativeKetamineReceptors, N-Methyl-D-Aspartatefunctional neuroimaginghippocampusketaminemagnetic resonance imagingN‐methyl‐D‐aspartate receptorsrecreational substance usesubstance‐related disordersworking memory

Identifiers

PMID41612591
PMCPMC13155325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.